SPINK1 and hepatocellular carcinoma: As a next step to bridge our findings to a more pre-clinical setting, it will be worthwhile to utilize this SPINK1 neutralizing antibody and test its effect in HCC patient-derived xenografts, alone or in combination with chemotherapy.